Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
The Annals of Pharmacotherapy
|
January 5, 2006
Methylene blue for management of Ifosfamide-induced encephalopathy
Priti N Patel
The Annals of Pharmacotherapy
|
July 12, 2007
Low-dose naltrexone for treatment of multiple sclerosis: clinical trials are needed
Priti N Patel
Drugs
|
June 27, 2008
Eculizumab in paroxysmal nocturnal haemoglobinuria
Lisa Charneski, Priti N Patel
Cardiology in Review
|
April 18, 2007
Varenicline: a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist approved for smoking cessation
Sum Lam, Priti N Patel
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
February 27, 2007
Rimonabant: a novel selective cannabinoid-1 receptor antagonist for treatment of obesity
Priti N Patel, Rolee Pathak
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
February 27, 2007
Facial flushing associated with duloxetine use
Danielle C Ezzo, Priti N Patel
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
November 6, 2009
Withdrawal symptoms after discontinuation of transdermal scopolamine therapy: treatment with meclizine
Priti N Patel, Danielle C Ezzo
Journal of the American Pharmacists Association : Japha
|
October 2, 2008
Caring for patients with celiac disease: the role of the pharmacist
Robert A Mangione, Priti N Patel
The Annals of Pharmacotherapy
|
April 30, 2009
Telavancin: a novel lipoglycopeptide antibiotic
Lisa Charneski, Priti N Patel, Donna Sym
The Open Neurology Journal
|
January 25, 2011
Disease modifying agents for multiple sclerosis
Olga Hilas, Priti N Patel, Sum Lam
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
The Annals of Pharmacotherapy
|
January 5, 2006
Methylene blue for management of Ifosfamide-induced encephalopathy
Priti N Patel
The Annals of Pharmacotherapy
|
July 12, 2007
Low-dose naltrexone for treatment of multiple sclerosis: clinical trials are needed
Priti N Patel
Drugs
|
June 27, 2008
Eculizumab in paroxysmal nocturnal haemoglobinuria
Lisa Charneski, Priti N Patel
Cardiology in Review
|
April 18, 2007
Varenicline: a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist approved for smoking cessation
Sum Lam, Priti N Patel
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
February 27, 2007
Rimonabant: a novel selective cannabinoid-1 receptor antagonist for treatment of obesity
Priti N Patel, Rolee Pathak
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
February 27, 2007
Facial flushing associated with duloxetine use
Danielle C Ezzo, Priti N Patel
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
November 6, 2009
Withdrawal symptoms after discontinuation of transdermal scopolamine therapy: treatment with meclizine
Priti N Patel, Danielle C Ezzo
Journal of the American Pharmacists Association : Japha
|
October 2, 2008
Caring for patients with celiac disease: the role of the pharmacist
Robert A Mangione, Priti N Patel
The Annals of Pharmacotherapy
|
April 30, 2009
Telavancin: a novel lipoglycopeptide antibiotic
Lisa Charneski, Priti N Patel, Donna Sym
The Open Neurology Journal
|
January 25, 2011
Disease modifying agents for multiple sclerosis
Olga Hilas, Priti N Patel, Sum Lam
Page
of 2